BD Announces Live Webcast Of Second Fiscal Quarter Earnings Conference Call

Mon Apr 8, 2013 2:00pm EDT

* Reuters is not responsible for the content in this press release.

For best results when printing this announcement, please click on the link
below:

http://pdf.reuters.com/pdfnews/pdfnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130408:nPnCL90588


FRANKLIN LAKES, N.J.,  April 8, 2013  /PRNewswire/ -- BD (Becton, Dickinson and
Company) (NYSE: BDX) announced today that it will conduct a live webcast of its
second fiscal quarter 2013 earnings conference call on  Thursday, May 2, 2013,
at  8:00 a.m. (ET).  BD will issue a press release detailing the quarter's
earnings earlier that morning.

The webcast of the conference call, along with related slides, will be
accessible through BD's website at  www.bd.com/investors  and will be available
for replay through  Thursday, May 9,  2013.     

About BD
BD is a leading global medical technology company that develops, manufactures
and sells medical devices, instrument systems and reagents.  The Company is
dedicated to improving people's health throughout the world.  BD is focused on
improving drug delivery, enhancing the quality and speed of diagnosing
infectious diseases and cancers, and advancing research, discovery and
production of new drugs and vaccines.  BD's capabilities are instrumental in
combating many of the world's most pressing diseases.  Founded in 1897 and
headquartered in  Franklin Lakes, New Jersey, BD employs nearly 30,000
associates in more than 50 countries throughout the world.  The Company serves
healthcare institutions, life science researchers, clinical laboratories, the
pharmaceutical industry and the general public.  For more information, please
visit  www.bd.com.

Contact:  
Monique N. Dolecki, Investor Relations - 201-847-5378
Colleen T. White, Corporate Communications - 201-847-5369

SOURCE  BD (Becton, Dickinson and Company)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.